What
Where
THE DEVELOPMENT OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELS TO DETERMINE THE OPTIMAL SAFE AND APPROPRIATE DOSE OF ONCOLOGY DRUGS FOR PREGNANT WOMEN W...
From: Federal Procurement Data System(Federal)
 Basic Details |  Start Date18 Sep, 2023 (7 months ago) Due Date24 Sep, 2024 (in 5 months) TypeContractIdentifier75F40123R00123 | ||||
 Customer / Agency | FOOD AND DRUG ADMINISTRATION | ||||
Unlock the best of InstantMarkets.Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.
Don't have an account yet? Create a free account now.
THE DEVELOPMENT OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELS TO DETERMINE THE OPTIMAL SAFE AND APPROPRIATE DOSE OF ONCOLOGY DRUGS FOR PREGNANT WOMEN WITH CANCER. Solicitation ID/Procurement Identifier: 75F40123R00123 Ultimate Completion Date: Tue Sep 24 17:00:00 GMT
Location
Address: 10430 OWEN BROWN RD,COLUMBIA,MARYLAND,USA
Country : United StatesYou may also like
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM - A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER
Due: 15 Sep, 2024 (in 4 months)PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO MARCH 24, 2025. N01DA-2...
Due: 24 Mar, 2025 (in 11 months)TO DETERMINE THE ANTIVIRAL INHIBITORY EFFECT AND CYTOTOXICITY OF EXPERIMENTAL ANTIVIRAL COMPOUNDS AGAINST VIRUSES IN GROUPS 3-5, AS WELL AS OTHER RAPIDLY EMERGI...
Due: 04 Sep, 2024 (in 4 months)Please Sign In to see more like these.
Don't have an account yet? Create a free account now.